Lig­no­caine patch

Pharmacy Daily - - NEWS -

CSL off­shoot Se­qirus has an­nounced the launch of its first Sched­ule 2 (OTC) prod­uct Ner­vo­derm, a dual-ac­tion med­i­cated patch con­tain­ing li­do­caine, “clin­i­cally proven to re­lieve nerve pain as­so­ci­ated with med­i­cally di­ag­nosed post-her­petic neu­ral­gia (PHN)”.

Ner­vo­derm has been launched in part­ner­ship with Pharmabro­ker Sales - see ner­vo­derm.com.au.

Newspapers in English

Newspapers from Australia

© PressReader. All rights reserved.